Rongbin Qi Hailing Xu Xinyu Fu Yingying Yu Dongqing Lv Yujing Li Susu He
10.3389/fonc.2023.1046266
Front Oncol
2023 Aug 1;13:1046266.
pm8001 immune checkpoint inhibitors immune-related adverse reactions keratoacanthoma type i diabetes
CC BY
https://pubmed.ncbi.nlm.nih.gov/37593095/
Case Reports
PMC10430778
37593095
Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-β and PD-L1
2023